New EU Post-licensing Legislation and Benefit-Risk Management, Berlin, 11-12 June 2012

May 14, 2012

Dr Jan Petracek of PharmInvent teaches at the upcoming 2-day course organized by the INTERNATIONAL SOCIETY OF PHARMACOVIGILANCE in Berlin. His lectures will be devoted to the following three topics: Efficacy and Effectiveness Specification, Risk Minimisation, Benefit Optimisation. The IsoP course will cover in detail the amendments to the EU Postmarketing legislation effective since July 2012, which represent the greatest change in medicines legislation in the last 10 years. Detailed information is available here.

Back to previous page...